Selective microembolization of the circumflex coronary artery in an ovine model: Dilated, ischemic cardiomyopathy and left ventricular dysfunction

被引:20
|
作者
Monreal, G
Gerhardt, MA
Kambara, A
Abrishamchian, AR
Bauer, JA
Goldstein, AH
机构
[1] Ohio State Univ, Dept Anesthesiol, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, Div Pharm, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43210 USA
[4] Scottsdale Heart Ctr, Scottsdale, AZ USA
关键词
heart failure; ventricular remodeling; coronary microembolization; myocardial infarction;
D O I
10.1016/j.cardfail.2003.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Ventricular remodeling often occurs after myocardial infarction, yet the natural history remains unpredictable because of the chronicity of the process and therapeutic interventions involved. We induced cardiac dysfunction in an ovine model via selective microembolization of the circumflex coronary artery (LCx) to test the hypothesis that ventricular remodeling progresses following coronary microembolization for up to 24 months. Methods and Results: Sheep underwent weekly selective microembolization of the LCx until left ventricular ejection fraction stabilized <35% for 2 consecutive weeks. In a subgroup carried out to 4 months, the end-systolic pressure-volume relationship slope decreased from 2.3 +/- 0.6 (baseline) to 1.3 +/- 0.5 at month 4 (P <.05). In a second group, echocardiography at 24 months, the ejection fraction decreased from 51 +/- 3% (baseline) to 25 +/- 2% (month 5) (P <.05) and stabilized through month 24 (23 +/- 5%, P <.05), whereas left ventricular end-systolic area and left ventricular end-diastolic area increased by 222% and 98%, respectively, through month 24. Conclusions: Selective microembolization of the LCx induces left ventricular dysfunction followed by dilated, ischemic cardiomyopathy, which continues to progress for up to 2 years despite stabilization of left ventricular ejection fraction. This model of ventricular remodeling secondary to microinfarction may be a useful experimental platform for large animal heart failure investigations.
引用
收藏
页码:174 / 183
页数:10
相关论文
共 50 条
  • [41] Anomalous origin of the left coronary artery from the pulmonary artery presenting as dilated cardiomyopathy
    Bakiler, Ali Rahmi
    Eliacik, Kayi
    Kose, Seda
    Atay, Yuksel
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 (05): : 448 - 450
  • [42] New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy
    Deepa M. Gopal
    Flora Sam
    Journal of Cardiovascular Translational Research, 2013, 6 : 516 - 527
  • [43] Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy
    Moon, Jeonggeun
    Ko, Young-Guk
    Chung, Namsik
    Ha, Jong-Won
    Kang, Seok-Min
    Choi, Eui-Young
    Rim, Se-Joong
    CANADIAN JOURNAL OF CARDIOLOGY, 2009, 25 (05) : E147 - E150
  • [44] Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction
    Wu, YW
    Yen, RF
    Chieng, PU
    Huang, PJ
    JOURNAL OF NUCLEAR CARDIOLOGY, 2003, 10 (04) : 369 - 374
  • [45] Sustained left ventricular diastolic dysfunction after exercise in patients with dilated cardiomyopathy
    Morikawa, M
    Sato, H
    Sato, H
    Koretsune, Y
    Ohnishi, Y
    Kurotobi, T
    Kuzuya, T
    Hori, M
    HEART, 1998, 80 (03) : 263 - 269
  • [46] Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy -: The randomized evaluation of strategies for left ventricular dysfunction pilot study
    Cirillo, W
    Decanini, R
    Coelho, OR
    Avezum, A
    Peixoto, MSP
    Piegas, LS
    Neto, JMR
    Paiva, M
    Carvalho, AC
    de Almeida, DR
    Fernandes, IML
    Malavasi, MC
    Pavanello, R
    Canesin, M
    Ishii, S
    Barretto, ACP
    Imrie, J
    Moore, R
    Woo, K
    Bernstein, V
    Mizgala, HF
    Mooney, S
    Hilbich, D
    Kuritzky, R
    Rupka, DW
    Blackwell, MM
    Breakwell, L
    Kornder, JM
    Pearce, SA
    Polasek, P
    Richardson, PM
    Grant, J
    Isaac, D
    Beresford, P
    Giannoccaro, P
    Roth, D
    Greenwood, P
    Muzyka, T
    Prosser, A
    Brass, N
    Hui, W
    Kvill, L
    Goeres, M
    MacDonald, K
    Senaratne, M
    Hill, L
    Humen, D
    Teo, KK
    Habib, N
    Habib, N
    CIRCULATION, 2000, 101 (04) : 378 - 384
  • [47] Clinical outcome following coronary artery stenting in patients with severe ischemic left ventricular dysfunction
    Zhang, SY
    Ventura, H
    Ramee, EJ
    Jain, SP
    Jenkins, JS
    Collins, T
    White, CJ
    Ramee, SR
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 : TC131 - TC131
  • [48] Prevalence of viable and ischemic myocardium in patients with chronic coronary artery disease and left ventricular dysfunction
    Kitsiou, A. N.
    Karas, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0B) : S11 - S12
  • [49] Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction
    Merlo, Marco
    Gentile, Piero
    Artico, Jessica
    Cannata, Antonio
    Paldino, Alessia
    De Angelis, Giulia
    Barbati, Giulia
    Alonge, Marco
    Gigli, Marta
    Pinamonti, Bruno
    Ramani, Federica
    Zecchin, Massimo
    Pirozzi, Fabrizio
    Stolfo, Davide
    Sinagra, Gianfranco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (05) : 343 - 350
  • [50] GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy
    Imazio, M
    Bobbio, M
    Broglio, F
    Benso, A
    Podio, V
    Valetto, MR
    Bisi, G
    Ghigo, E
    Trevi, GP
    EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (02) : 185 - 191